Ju Li

6.2k citations

94 papers · 4.5k indexed · 3 hit papers · h-index 23

Impact in

Genetics top 0.5%
- Inflammatory Bowel Disease
Epidemiology top 1%
- Microscopic Colitis
- Autoimmune and Inflammatory Disorders

Papers in ⓘ

Molecular Biology 41
- CRISPR and Genetic Engineering 15
- RNA and protein synthesis mechanisms 9
- Muscle Physiology and Disorders 8
- Advanced biosensing and bioanalysis techniques 6
- RNA regulation and disease 6
Pathology and Forensic Medicine 13
- Lymphoma Diagnosis and Treatment 9

Co-authors: Remo Panaccione (4 shared papers)William J. Sandborn (4 shared papers)Jeffrey D. Kent (3 shared papers)Paul F. Pollack (3 shared papers)Paul Rutgeerts (3 shared papers)Robert Enns (1 shared paper)Stefan Schreiber (1 shared paper)Stephen B. Hanauer (1 shared paper)
Journals: Medical Physics (8 papers)Nature Communications (5 papers)ACS Synthetic Biology (3 papers)Journal of Animal Science (3 papers)Blood (3 papers)
Partner nations: China United States South Korea

In The Last Decade

Ju Li

93 papers receiving 4.4k citations

Hit Papers

align trajectories log scale

Glycosylase base editors enable C-to-A and C-to-G base changes 2020 · 346 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Nature Biotechnology
2007 Annals of Internal Medicine
2006 Gastroenterology

Peers

Countries citing papers authored by Ju Li

Since Specialization

Citations

This map shows the geographic impact of Ju Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju Li more than expected).

Fields of papers citing papers by Ju Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju Li. The network helps show where Ju Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Ju Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ju Li Line = papers co-authored together Ju Li links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial Gastroenterology ·Jean–Frédéric Colombel, William J. Sandborn, Paul Rutgeerts, Robert Enns, Stephen B. Hanauer, Remo Panaccione, Stefan Schreiber, Dan Byczkowski, Ju Li, Jeffrey D. Kent, Paul F. Pollack Hit paper breakdown →	2006	1655
2	Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab Annals of Internal Medicine ·William J. Sandborn, Paul Rutgeerts, Robert Enns, Stephen B. Hanauer, Jean‐Frédéric Colombel, Remo Panaccione, Geert D’Haens, Ju Li, Marie R. Rosenfeld, Jeffrey D. Kent, Paul F. Pollack Hit paper breakdown →	2007	740
3	Glycosylase base editors enable C-to-A and C-to-G base changes Nature Biotechnology ·Dongdong Zhao, Ju Li, Siwei Li, Xiuqing Xin, Muzi Hu, Marcus A. Price, Susan J. Rosser, Changhao Bi, Xueli Zhang Hit paper breakdown →	2020	346
4	Oxytocin is an age-specific circulating hormone that is necessary for muscle maintenance and regeneration Nature Communications ·Christian Elabd, Wendy Cousin, Pavan S. Upadhyayula, Robert Y. Chen, Marc S. Chooljian, Ju Li, Sunny Kung, Kevin P. Jiang, Irina M. Conboy	2014	304
5	ERK2 is required for efficient terminal differentiation of skeletal myoblasts Biochemical and Biophysical Research Communications ·Ju Li, Sally Johnson	2006	121
6	Adalimumab safety in global clinical trials of patients with Crohnʼs disease Inflammatory Bowel Diseases ·Jean–Frédéric Colombel, William J. Sandborn, Remo Panaccione, Anne Robinson, Winnie Lau, Ju Li, Alexandra Cardoso	2009	103
7	A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid®) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: The EXPECT trial European Journal of Cancer ·Franck Morschhauser, Olivier Fitoussi, Corinne Haïoun, Catherine Thiéblemont, Hang Quach, Richard Delarue, Sylvie Glaisner, Jean Gabarre, André Bosly, John Lister, Ju Li, Bertrand Coiffier	2013	95
8	Fetal and neonatal programming of postnatal growth and feed efficiency in swine Journal of Animal Science and Biotechnology ·Yun Ji, Zhenlong Wu, Zhaolai Dai, Xiaolong Wang, Ju Li, Binggen Wang, Guoyao Wu	2017	77
9	Dietary Fiber Ameliorates Lipopolysaccharide-Induced Intestinal Barrier Function Damage in Piglets by Modulation of Intestinal Microbiome mSystems ·Xiao Sun, Yalei Cui, Yingying Su, Zimin Gao, Xinying Diao, Ju Li, Xiaoyan Zhu, Defeng Li, Zhentian Li, Chengzhang Wang, Yinghua Shi	2021	53
10	Biosensor for Asparagine Using a Thermostable Recombinant Asparaginase from Archaeoglobus fulgidus Analytical Chemistry ·Ju Li, Jianquan Wang, Leonidas G. Bachas	2002	44
11	Glycosylase-based base editors for efficient T-to-G and C-to-G editing in mammalian cells Nature Biotechnology ·Lijun Ye, Dongdong Zhao, Ju Li, Yiran Wang, Bo Li, Yuanzhao Yang, Xueting Hou, Huibin Wang, Zhandong Wei, Xiaoqi Liu, Yaqiu Li, Siwei Li, Yajing Liu, Xueli Zhang, Changhao Bi	2024	42
12	Age-Specific Functional Epigenetic Changes in p21 and p16 in Injury-Activated Satellite Cells Stem Cells ·Ju Li, Suhyoun Han, Wendy Cousin, Irina M. Conboy	2014	41
13	WE-E-ValA-06: A Real-Time MRI Guided External Beam Radiotherapy Delivery System Medical Physics ·James Dempsey, B. Dionne, Jeffrey R. Fitzsimmons, A Haghigat, Ju Li, Daniel A. Low, Sasa Mutic, Jatinder Palta, H. Edwin Romeijn, Glenn Sjoden	2006	38
14	Evidence of heterogeneity within bovine satellite cells isolated from young and adult animals Journal of Animal Science ·Ju Li, J. M. Gonzalez, Dillon K. Walker, Matt Hersom, Alan D. Ealy, Sally Johnson	2011	36
15	The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non‐Hodgkin lymphoma of distinct histological origin British Journal of Haematology ·Myron S. Czuczman, Julie M. Vose, Thomas E. Witzig, Pier Luigi Zinzani, Rena Buckstein, Jonathan Polikoff, Ju Li, Dennis Pietronigro, A. Ervin-Haynes, Craig B. Reeder	2011	34
16	A review of the mechanism of action of Dantonic® for the treatment of chronic stable angina Biomedicine & Pharmacotherapy ·Wenjing Liao, Xiaohui Ma, Ju Li, Xinxin Li, Zhi‐Xin Guo, Shuiping Zhou, He Sun	2018	33
17	Hepatocyte growth factor (HGF) signals through SHP2 to regulate primary mouse myoblast proliferation Experimental Cell Research ·Ju Li, Sarah Reed, Sally Johnson	2009	32
18	Aberrant expression of microRNA in CD4+ cells contributes to Th17/Treg imbalance in primary immune thrombocytopenia Thrombosis Research ·Mingqiang Hua, Ju Li, Chunyan Wang, Linlin Shao, Ming Hou, Jun Peng, Qi Feng	2019	31
19	AAV-mediated base-editing therapy ameliorates the disease phenotypes in a mouse model of retinitis pigmentosa Nature Communications ·Yidong Wu, Xiaoling Wan, Dongdong Zhao, Xuxu Chen, Yujie Wang, Xinxin Tang, Ju Li, Siwei Li, Xiaodong Sun, Changhao Bi, Xueli Zhang	2023	29
20	Single‐agent lenalidomide is active in patients with relapsed or refractory aggressive non‐Hodgkin lymphoma who received prior stem cell transplantation British Journal of Haematology ·Julie M. Vose, Thomas M. Habermann, Myron S. Czuczman, Pier Luigi Zinzani, Craig B. Reeder, Joseph M. Tuscano, Izidore S. Lossos, Ju Li, Dennis Pietronigro, Thomas E. Witzig	2013	29

About Ju Li

Ju Li is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 94 papers that have together received 4.5k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (15 papers), RNA and protein synthesis mechanisms (9 papers), Lymphoma Diagnosis and Treatment (9 papers), Muscle Physiology and Disorders (8 papers), Advanced biosensing and bioanalysis techniques (6 papers), Advanced Radiotherapy Techniques (6 papers), RNA regulation and disease (6 papers) and Inflammatory Bowel Disease (4 papers). The work is most often cited by research in Genetics (2.5k citations), Epidemiology (1.9k citations), Aging (94 citations), Immunology (797 citations) and Hematology (282 citations). Ju Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Remo Panaccione, William J. Sandborn, Jeffrey D. Kent, Paul F. Pollack, Paul Rutgeerts, Robert Enns, Stefan Schreiber, Stephen B. Hanauer, Jean–Frédéric Colombel and Sally Johnson. Their work appears in journals such as Medical Physics, Nature Communications, ACS Synthetic Biology, Journal of Animal Science and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact